NovaBay Pharmaceuticals, Inc. 8-K

What Happened

• NovaBay Pharmaceuticals, Inc. filed a Form 8-K on March 23, 2026 announcing it will change its name to "Stablecoin Development Corporation" and expects the new name to begin trading on April 3, 2026. The company also announced a ticker symbol change: its NYSE American listing will move from "NBY" to "SDEV" at market open on April 3, 2026.
• In the same press release (furnished as Exhibit 99.1), NovaBay disclosed updated on-chain activity and cryptocurrency holdings: as of March 16, 2026, the company holds approximately 2.06 billion SKY tokens and engages in SKY-related on-chain activities, including staking and accumulated staking rewards.

Key Details

• Filing date: March 23, 2026; name and ticker change effective at market open on April 3, 2026.
• Reported SKY holdings: approximately 2.06 billion SKY tokens (as of March 16, 2026).
• Company activity: engaged in on-chain activities, including staking; press release referenced initial staking rewards and a previously disclosed strategic investment/on-chain holding company strategy.
• Press release attached as Exhibit 99.1 to the 8-K.

Why It Matters

• The name and ticker change signals a formal shift in corporate focus toward stablecoin/on‑chain business activities; investors should note the rebrand and its timing for trading and ticker lookup.
• The disclosure of a large SKY token holding and staking activity is material information about the company’s crypto exposure and operational strategy; this could affect how investors evaluate the company’s assets and risk profile.
• Retail investors should watch subsequent SEC filings and company disclosures for details on how crypto holdings and staking rewards are accounted for, and for any additional financial impact or strategic developments.